BioPak Limited – Corporate Profile – April 2007
Business: World Class Manufacturing in Canada
Currently, BioPak Limited is a contract manufacturer of branded, high-quality nutritional supplements in the form of tablets and capsules. BioPak provides a comprehensive range of services covering all aspects of the process
- from (1) product conception and design
(2) raw material procurement to
(3) product formulation and product manufacture to
(4) custom packaging solutions.
The company is recognized as a trusted and capable leader in this field.
Since its establishment in December of 1995, BioPak has experienced significant success: steady growth from $45K in 1996 to $400K in 1999, the rapid growth to $6M in 2004. In fact, BioPak Ltd. was recognized as #36 of the Top 100 fastest growing companies in Canada in 2004. BioPak projects US$10.61M gross revenue for its May07-Apr08 fiscal year and expects to earn more than US$2.65M gross profit based on its current business model and customer base.
However, BioPak has the opportunity and ability to expand its current contract manufacturing business into other dosage forms (such as liquids, creams, oils and soft gels) and to move its business activities to another level by (1) licensing and re-branding existing products for distribution into new markets and by (2) creating its own brands for world-wide distribution. Senior management at BioPak has already begun to implement the internal changes and build the external relationships required to successfully accomplish these goals.
Facility: World Class Building and Equipment
Constructed in 2003, with over US$1 million in leasehold improvements when BioPak occupied the building as its only tenant (today’s cost for similar improvements would exceed US$2 million).40,000 sq. ft. (3,700 sq. meters) state-of-the-art building - housing a full range of modern equipment with substantial remaining life-spans. BioPak also rents an additional 5,000 sq. ft. warehouse space in an adjacent building for additional inventory storage.
Building rented at below current market prices - 4 years remain on the rental agreement - BioPak has first right for renewal of the agreement.
State-of-the-art security systems, including 12 camera, remote access, video surveillance system.
High-quality heating, ventilation and air conditioning systems.
Ample parking facilities on recently paved and landscaped grounds (parking for customers, suppliers, management and administrative staff in front, parking for production and warehouse staff in rear).
Building is fully insulated with all interior surfaces (including ceilings) designed for easy maintenance and cleaning.
Excellent facilities for all staff, including modern lunchroom, washrooms, and changing rooms.
Capability and Capacity: World Class Ability with Scale-Up Potential
Provides a full range of manufacturing capability from product conception to finished product.
Recognized as a world leader in (1) rapid production, (2) excellent customer service and (3) dependable delivery of high-quality products.
Accreditation: Natural Health Products Directorate Site License (which validates BioPak’s Good Manufacturing Practices status) and Health Canada Controlled Substance License.
One of the first North American facilities approved by the Saudi Ministry of Health for the manufacture of herbal and dietary supplements for distribution to the Saudi Arabian market.
Ability and existing space to expand manufacturing capability to include liquids, creams, oils and soft gels.
Ability to move business activities to another level by (1) licensing and re-branding existing products for distribution into new markets and by (2) creating its own brands for world-wide distribution.
Ability to run 24 hours per day / 7 days per week, for maximum annual production capacities of: Blending – 5000 metric tones, Encapsulation – 2 billion capsules, Tablet Pressing – 2 billion tablets, Bottling – 75 million bottles, and Packaging – 100 million blister cards.
Estimated Replacement Cost of BioPak’s World Class Facility
The Province of Alberta, Canada, where BioPak is located, has experienced a significant economic boom during the past few years. Due in large part to increased oil prices, the cost of land, buildings and material has increased dramatically. This means that establishing a new facility with capacity and capability similar to BioPak’s would be a comparably expensive proposition.
BioPak management estimates that the total cost for duplicating the existing facility would be US$10 million or more.
Staffing
• BioPak possesses an excellent management team and a highly trained production staff. Current staffing levels are: 32 in total, 20 in production and shipping, 12 in management and operational / administrative support.
• During periods of peak activity, BioPak has employed up to 100 people. The company has the ability to quickly adjust manpower to accommodate changes in demand and meet the required production levels.
BioPak Limited – The Future
As stated previously, BioPak has the opportunity and ability to expand its current contract manufacturing business into other dosage forms (such as liquids, creams, oils and soft gels) and to move its business activities to another level by (1) licensing and re-branding existing products for distribution into new markets and by (2) creating its own brands for world-wide distribution.
Mr. Bret Smith (President and CEO) and Mr. Gordon Stranks (Business Consultant) have already begun to implement the internal changes and extend or build the external relationships required to successfully accomplish these goals.
Mr. Smith and Mr. Stranks are in the process of restructuring BioPak’s business model and establishing new strategic goals for the company. Actions and initiatives in progress include, but are not limited to the following:
Staffing and management restructuring designed to reduce expense while increasing productivity.
Renegotiation of customer contracts to enable higher margins.
Renegotiation of supplier prices to reduce materials costs.
Aligning customer base with BioPak core competency and required margins.
Renewed emphasis on exemplary customer service.
Identification of potential products for licensing, manufacture, re-branding and distribution into new markets.
Exploration of existing and emerging product opportunities for purchase and “own branding” by BioPak.
Considering BioPak’s opportunity and ability to move its business activities to another level, management believes it can rapidly and substantially increase both gross revenue and gross profit above the current projections that were based upon the company’s prior operational efficiency and business model.
Since its establishment in December of 1995, BioPak has experienced significant success: steady growth from $45K in 1996 to $400K in 1999, the rapid growth to $6M in 2004. In fact, BioPak Ltd. was recognized as #36 of the Top 100 fastest growing companies in Canada in 2004. BioPak projects US$10.61M gross revenue for its May07-Apr08 fiscal year and expects to earn more than US$2.65M gross profit based on its current business model and customer base.
However, BioPak has the opportunity and ability to expand its current contract manufacturing business into other dosage forms (such as liquids, creams, oils and soft gels) and to move its business activities to another level by (1) licensing and re-branding existing products for distribution into new markets and by (2) creating its own brands for world-wide distribution. Senior management at BioPak has already begun to implement the internal changes and build the external relationships required to successfully accomplish these goals.
Facility: World Class Building and Equipment
Constructed in 2003, with over US$1 million in leasehold improvements when BioPak occupied the building as its only tenant (today’s cost for similar improvements would exceed US$2 million).40,000 sq. ft. (3,700 sq. meters) state-of-the-art building - housing a full range of modern equipment with substantial remaining life-spans. BioPak also rents an additional 5,000 sq. ft. warehouse space in an adjacent building for additional inventory storage.
Building rented at below current market prices - 4 years remain on the rental agreement - BioPak has first right for renewal of the agreement.
State-of-the-art security systems, including 12 camera, remote access, video surveillance system.
High-quality heating, ventilation and air conditioning systems.
Ample parking facilities on recently paved and landscaped grounds (parking for customers, suppliers, management and administrative staff in front, parking for production and warehouse staff in rear).
Building is fully insulated with all interior surfaces (including ceilings) designed for easy maintenance and cleaning.
Excellent facilities for all staff, including modern lunchroom, washrooms, and changing rooms.
Capability and Capacity: World Class Ability with Scale-Up Potential
Provides a full range of manufacturing capability from product conception to finished product.
Recognized as a world leader in (1) rapid production, (2) excellent customer service and (3) dependable delivery of high-quality products.
Accreditation: Natural Health Products Directorate Site License (which validates BioPak’s Good Manufacturing Practices status) and Health Canada Controlled Substance License.
One of the first North American facilities approved by the Saudi Ministry of Health for the manufacture of herbal and dietary supplements for distribution to the Saudi Arabian market.
Ability and existing space to expand manufacturing capability to include liquids, creams, oils and soft gels.
Ability to move business activities to another level by (1) licensing and re-branding existing products for distribution into new markets and by (2) creating its own brands for world-wide distribution.
Ability to run 24 hours per day / 7 days per week, for maximum annual production capacities of: Blending – 5000 metric tones, Encapsulation – 2 billion capsules, Tablet Pressing – 2 billion tablets, Bottling – 75 million bottles, and Packaging – 100 million blister cards.
Estimated Replacement Cost of BioPak’s World Class Facility
The Province of Alberta, Canada, where BioPak is located, has experienced a significant economic boom during the past few years. Due in large part to increased oil prices, the cost of land, buildings and material has increased dramatically. This means that establishing a new facility with capacity and capability similar to BioPak’s would be a comparably expensive proposition.
BioPak management estimates that the total cost for duplicating the existing facility would be US$10 million or more.
Staffing
• BioPak possesses an excellent management team and a highly trained production staff. Current staffing levels are: 32 in total, 20 in production and shipping, 12 in management and operational / administrative support.
• During periods of peak activity, BioPak has employed up to 100 people. The company has the ability to quickly adjust manpower to accommodate changes in demand and meet the required production levels.
BioPak Limited – The Future
As stated previously, BioPak has the opportunity and ability to expand its current contract manufacturing business into other dosage forms (such as liquids, creams, oils and soft gels) and to move its business activities to another level by (1) licensing and re-branding existing products for distribution into new markets and by (2) creating its own brands for world-wide distribution.
Mr. Bret Smith (President and CEO) and Mr. Gordon Stranks (Business Consultant) have already begun to implement the internal changes and extend or build the external relationships required to successfully accomplish these goals.
Mr. Smith and Mr. Stranks are in the process of restructuring BioPak’s business model and establishing new strategic goals for the company. Actions and initiatives in progress include, but are not limited to the following:
Staffing and management restructuring designed to reduce expense while increasing productivity.
Renegotiation of customer contracts to enable higher margins.
Renegotiation of supplier prices to reduce materials costs.
Aligning customer base with BioPak core competency and required margins.
Renewed emphasis on exemplary customer service.
Identification of potential products for licensing, manufacture, re-branding and distribution into new markets.
Exploration of existing and emerging product opportunities for purchase and “own branding” by BioPak.
Considering BioPak’s opportunity and ability to move its business activities to another level, management believes it can rapidly and substantially increase both gross revenue and gross profit above the current projections that were based upon the company’s prior operational efficiency and business model.
Aucun commentaire:
Enregistrer un commentaire